miR-1 could decrease the expression of EGFR, PCR1, PCR2, and p-JNK by targeting ANXA2 and Met, thus inhibiting the growth of glioma cells and tumor angiogenesis and reducing the invasiveness of glioma cells (81). This evidence concerns the gene ANXA2 and central nervous system cancer.